Cerebrospinal meningitis Update

Cerebrospinal meningitis Update

A CSM patient

Situation Report  (As at 6th April 2017): 3,959 suspected cases with 438 deaths

  • As at 5th April 2017, a  total of 3,959 suspected cases with 438 deaths (CFR=11.1%)  have been reported from 106 LGAs
  • outbreaks are currently reported in 19 States with five States mostly affected.
  • Zamfara, Katsina, Kebbi and Sokoto States in the North-West zone, and Niger State in the North-Central zone account for about 95% of the cases reported
  • A total of 181 positive cases confirmed by Pastorex and Culture; Neisseria meningitides serotype C being the most common serotype accounting for 83% of laboratory confirmed cases
  • The most common serotype is Neisseria meningitidis serotype C (Nm C)
  • The most affected age group is 5-14 years and accounts for 52% of cases
  • Reactive vaccination campaign started on the 5th of April 2017 in Zamfara State with massive turnout in all the targeted communities
  • A joint team of NCDC, NPHCDA and partners is supporting the reactive vaccination campaign and outbreak response in Zamfara State.
  • Source: NCDC

About author

You might also like

PHARMA NEWS 0 Comments

Fidson Pharma rewards Astymin users

… Rolls out cash promo Users of Astymin brand of multivitamin, will now gain financial and nutritional reward through constant use of the multivitamin. Makers of the brand, Fidson Pharmaceuticals

Be prepared for next pandemic after COVID 19 – West African lab scientists alert countries

Considering the short period it took for the world to move from one pandemic to the other in modern times, compared to such occurrences earlier in history, the West African

Chinese company sells faulty vaccines

  The Chinese pharmaceuticals industry suffered another blow on Monday (July 23) following reports that hundreds of thousands of children may have been inoculated with faulty vaccines from major drug

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply